| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
| 12/2003 | An open-label, prospective study of an oral polyvalent bacterial lysate (Luivac) in the treatment of recurrent respiratory tract infections in Thai patients. |
Disease
|
Drug/Important Bio-Agent (IBA)
|
Therapy/Procedure
|